BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• The Global Addiction Treatment Market to Grow 1.5X at a CAGR of 6.7% by 2025

  Fact.MR – A Market research and competitive intelligence provider: The global addiction treatment market size is poised to expand at a CAGR of 6.7% during the forecast period.

  February 17, 2022

   · 

  12 min read
• Global Ambulatory EHR Market Competitive Analysis, Key Trends and Growing Demand (2019-2029)

  The integration of healthcare IT solutions with EHR stands as the key factor promoting the growth of the global ambulatory EHR market during the forecast period, 2019 - 2029.

  February 17, 2022

   · 

  5 min read
• AR in healthcare Market Survey Report | Augmented reality in Healthcare and Medicine

  Rise in use of augmented reality in the healthcare sector for various activities such as surgical simulation, diagnostic imaging, patient care management, and rehabilitation is boosting the sales opportunities in the global AR in healthcare market.

  February 17, 2022

   · 

  5 min read
• Ambulance Services Market: Ground Ambulances Segment Holding Highest Shares Owing to Wide Preference during Emergency Services

  Hefty traffic, expanding metropolitan populace, and the rising interest for pre-medical clinic crisis services have catalyzed the requirement for engine ambulances.

  February 17, 2022

   · 

  6 min read
• Drug Development

  Valbiotis Announces Approval to Launch the Two Phase II/III INSIGHT and INSIGHT 2 Clinical Studies, the Last Step in the Development of TOTUM•854 For the Reduction of Blood Pressure

  Valbiotis announces that it has received approval to launch the two international multicenter Phase II/III INSIGHT and INSIGHT 2 clinical studies on TOTUM•854, for the reduction of blood pressure.

  February 17, 2022

   · 

  5 min read
• IMMray™ PanCan-d - peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology

  Immunovia AB announces that the peer-reviewed, blinded study to independently validate the clinical performance of IMMray™ PanCan-d has been published in Clinical and Translational Gastroenterology.

  February 17, 2022

   · 

  4 min read
• Business

  Oncopeptides publishes year-end report 2021

  Oncopeptides AB, a biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has published the year-end report 2021.

  February 17, 2022

   · 

  4 min read
• Business

  Sartorius presents annual report for 2021

  The life science group Sartorius has presented its 2021 Annual Report.

  February 17, 2022

   · 

  4 min read
• Biotech Beach

  Prometheus Laboratories Announces the Launch of PredictrPK™ IFX, A Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel Disease

  Prometheus Laboratories Inc., a leader of precision healthcare, announced the launch of PredictrPK IFX, a test that aids healthcare providers with biologic dose optimization through individualized pharmacokinetic modeling.

  February 17, 2022

   · 

  4 min read
• Business

  Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update

  Immunic, Inc. today announced that the company will release its financial results for the fourth quarter and year ended December 31, 2021, including a corporate update, on Thursday, February 24, 2022, before the opening of the U.S. financial markets.

  February 17, 2022

   · 

  4 min read